du Bois R M
Royal Brompton National Heart and Lung Hospital, London.
Br J Hosp Med. 1992;47(9):680-3.
Fibrosing alveolitis kills half of those who suffer from it within 5 years of diagnosis. Its incidence appears to be increasing and the response to treatment is disappointing. This article explores the reasons why the response to treatment is poor and ways in which new approaches to treatment might be developed.
纤维化肺泡炎患者在确诊后5年内，有一半会死亡。其发病率似乎在上升，而治疗效果却令人失望。本文探讨了治疗效果不佳的原因以及可能开发新治疗方法的途径。
